Amisha Wallia MD MS is an internationally recognized leader in the field of diabetes and its complications who has used novel methodologies, including pragmatic trials, health record linking, and user-centered design, to bring about clinical practice changes for high risk, marginalized populations. She is currently an Associate Professor (with Tenure) at the Northwestern University Feinberg School of Medicine within the Division of Endocrinology, Metabolism and Molecular Medicine, the Center for Health Services and Outcomes Research, and the Division of Epidemiology. She began her physician-scientist career in 2011, starting an integrated clinical diabetes research program within the health care system for high-risk hospitalized patients (recurrent diabetic ketoacidosis, post-transplant), creating one of the first learning health systems in diabetes care. Utilizing novel methods, her work has not only led to the identification of numerous deleterious effects of both hyperglycemia and hypoglycemia in under-represented populations but has also led to impactful changes in care pathways for patients under-represented in clinical trials.

Her work has led to leadership roles on Steering Committees of several international groundbreaking multi-center clinical trials and epidemiologic studies related to pre-diabetes, diabetes (Type 1 and 2) and its complications (Diabetes Prevention Program Outcomes Study, Preventing Early Renal Loss in Diabetes Study, Epidemiology of Diabetes Interventions and Complications Study, CITI Islet Cell Consortium).

Dr. Wallia has developed numerous clinical and population-based programs (Chicagoland, Illinois Collaboratives), and has conducted research spanning pragmatic trials, implementation science and population-based health. Her work has been continuously funded through NIH, Agency for Healthcare Research and Quality, and the American Diabetes Association (ADA) since 2012, and she now serves as Chair for Healthcare Delivery and Economics for the ADA Scientific Sessions. She has served as PI on R grants focused on re-designing both interventions and implementation strategies in the clinical setting to improve diabetes related care.